Asia-Pacific life science instrumentation market is projected to grow at a significant CAGR of around 6.9% during the forecast period, owing to the increased R&D and investments by big pharmaceutical companies in life science research. Increasing public health care programs in the emerging economies despite the economic slowdown is estimated to support healthcare spending in the region. According to the Centers for Medicare & Medicaid Services, healthcare spending increased by an annual average of 6.6% from 2015 to 2019 in the region. Therefore, the growing investment in the healthcare sector further encourages the R&D in life science that further projected to provide ample opportunity to the growth of the market.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-life-science-instrumentation-market
Moreover, growing healthcare facilities in the emerging economies such as China, India and other countries of the region provide significant demand for life science instrumentation that further contribute to the growth of the market. The substantial growth in healthcare facilities is predicted in India at a rate of 16.1% per year due to the government investments in raising public health expenditure from its current equivalent of 1.2% of GDP to 2.5% of GDP within five years. China’s spending growth is estimated to be 8.8% a year, however, the current economic uncertainty can result in the decline of the healthcare expenditure that further affects the growth in these countries. Australia and South Korea are expecting growth of over 4.0% a year.
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- How will COVID-19 impact the market growth in 2020 and the coming years?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
o Recommendations
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Asia-Pacific Life Science Instrumentation Market – Segmentation
By Technology
- Chromatography
- Spectroscopy
- Polymerase Chain Reaction (PCR)
- Clinical Chemistry Analyzers
- Immunoassays
- Next-Generation Sequencing (NGS)
- Flow Cytometry
- Microscopy
- Others (Centrifuges, Electrophoresis)
By End-User
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Hospitals and Laboratories
A full report of Asia-Pacific Life Science Instrumentation Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-life-science-instrumentation-market
Company Profiles
· Danaher Corp.
· General Electric Co.
· Hitachi High-Tech Corp.
· HORIBA, Ltd.
· JEOL Ltd.
· Merck KGaA
· PerkinElmer Inc.
· QIAGEN GmbH
· Shimadzu Corp.
· Thermo Fisher Scientific Inc.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
